Term
|
Definition
Phosphodiesterase Inhibitor
- such that CAMP does not get degraded |
|
|
Term
|
Definition
Phosphodiesterase Inhibitor
- prevents CAMP from being degraded to 5' AMP |
|
|
Term
|
Definition
Phosphodiesterase Inhibitor
- which prevents CAMP from degradation to 5' AMP
Tx Impotence |
|
|
Term
|
Definition
Phosphodiesterase Inhibitors
- which prevents CGMP from degradation to 5' GMP which can lead to severe vasodilation
TX Impotence |
|
|
Term
Phenobarbital and other barbiturates |
|
Definition
Stimulate Synthesis of hepatic CYP450 |
|
|
Term
|
Definition
Stimulate the synthesis of hepatic CYP450 |
|
|
Term
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
Cigarette smoke (benzopyrene) |
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
Dioxin (TCDD) - agent orange |
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
Polychlorinated biphenyls (PCB's) |
|
Definition
Stimulate the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
INHIBIT the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
INHIBIT the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
INHIBIT the synthesis of hepatic CYP450
Peripheral Neuropathy (USMLE)
|
|
|
Term
|
Definition
INHIBIT the synthesis of hepatic CYP450
Stimulate Modulin in GI tract
|
|
|
Term
|
Definition
INHIBIT the synthesis of hepatic CYP450
|
|
|
Term
Furanocoumarin (grape juice) |
|
Definition
INHIBIT the synthesis of hepatic CYP450
|
|
|
Term
|
Definition
Carbonic Anhydrase Inhibitor
Make Urine Basic
Increases the excretion of weak acids by making urine alkaline
Salicylic Acid hyrdrolyzed from apsirin is a weak acid
TX of Glaucoma
Decrease the production of aqueous humor
S/E: headache, dec libido, kidney stones, etc
say no to p.o. |
|
|
Term
|
Definition
Makes Urine Acidic
Increase the excretion of weak bases
Ex. Amphetamine |
|
|
Term
|
Definition
SLOW acetylators
hepatic damage and blood dyscrasias |
|
|
Term
|
Definition
SLOW acetylators
Relaxes Vascular Smooth Muscle to Lower BP
Increase HR via the arterial baroreflexes
INDIRECT
lupus-like syndrome |
|
|
Term
|
Definition
SLOW acetylators
lupus-like syndrome |
|
|
Term
|
Definition
|
|
Term
|
Definition
Cholinergic agonist
Cardiac: (i.v.) causes a rapide and transient decrease in BP (via NO in endothelial cells) and baroreflexly-mediated tachycardia
After TX with Atropine the i.v. injection increase BP and heart rate by stimulating N1 cholinergic receptors at symp ganglia
Eye: cause rapid and complete MIOSIS |
|
|
Term
|
Definition
Cholinergic agonist (muscarinic receptor agon)
Used as a provocative agent in diagnosis of BRONCHIAL ASTHMA
|
|
|
Term
Carbachol (Carbamylcholine) |
|
Definition
Cholinergic agonist at nicotinic and muscarinic receptors
causes MIOSIS
|
|
|
Term
|
Definition
Cholinergic agonist
given P.O., its the only one with systemic use
TX bowel stasis, paralytic ileus, urinary retention
do not use with pilocarpine or people with COPD, asthma, hyperthryoid, ulcers
|
|
|
Term
|
Definition
Cholinergic (muscaranic) agonist
HEART:
Decrease HR
Direct Action at the SA Node
Tertiary Amine
Degraded by hepatic enzymes not AChase or pseudocholinesterase
TX: Dry mouth and Dry eyes (Sjogren's syndrome) |
|
|
Term
|
Definition
Cholinergic agonist (muscarinic)
TX: Sjogren's (dry mouth and dry eyes)
|
|
|
Term
|
Definition
TX of Glaucoma
MOA: Contracts the meridional fibers of the ciliary muscle increasing the IC angle or tone of the trabeculae allowing better flow of aq humor
Can cause fixation of the lens for near vision
Persistent miosis causes poor night vision (headache)
Contraindicated: asthma & COPD, peptic ulcer, atrial flutter |
|
|
Term
|
Definition
B-adrenoreceptor antagonists, selective for beta 1
TX Glaucoma and IOP, w/ no effect on visual accomodation or pupillary size , by reducing aqueous humor production.
MOA: Decreases prodcution of aq. humor
Can cause bradycardia
|
|
|
Term
|
Definition
B adrenoreceptor antagonist (b1 & b2)
TX Glaucoma and IOP
MOA: decrease aqueus humor
Side Effects: Can cause bronchoconstriction |
|
|
Term
|
Definition
Stable analog of PGF (2alpha)
TX Glaucoma and IOP
Increase uveoscleral outflow
more efficacious than unoprostone
|
|
|
Term
|
Definition
alpha Adrenergic Agonist
Increase normal outflow
Cause MYDRIASIS w/ dipivefrin bound to it due to alpha 1 stimulation of radial muscle
TX Glaucoma and IOP
MOA: alpha 1 - enhances outflow of aqueous humor via the normal pathway
|
|
|
Term
|
Definition
TX of Glaucoma and IOP
hyrolyzed to epinephrine (alpha 1)
increases normal outflow and cause MYDRIASIS with epinephrine
|
|
|
Term
|
Definition
alpha adrenoceptor agonists
selective for alpha 2
TX of Glaucoma and IOP
Decreasing the rate of production of aqueous humor
|
|
|
Term
|
Definition
carbonic anhydrase inhibitor
TX of Glaucoma and IOP
decrease the production of aq. humor
|
|
|
Term
|
Definition
Inhibitors of AChase
(organophosphate cholinesterase inhibitor)
MOA: Lower IOP by increasing the amount of ACH available to contract meridional fibers of the ciliary muscle
TX of Glaucoma and IOP
"last resort drug"
|
|
|
Term
|
Definition
TX of Glaucoma
Organophosphate AChase Inhibitors
MOA: Lower IOP by increasing the amount of ACh available to contract meridional fibers of the ciliary muscle |
|
|
Term
|
Definition
Osmotic Diuretic
TX of ACUTE ATTACK of Angle Closure Glaucoma
Given IV and does not leave ECF
|
|
|
Term
|
Definition
Carbamate ACHase inhibitors
Tertiary amine - freely enters CNS
MOA: 1. noncompetitive, slowly reversible inhibition of AChase
2. Cause carbamoylation of AChase active site
3. No direct affect at ACh receptors
TX. Alzheimers (improves behavior and cognition)
many side effects
excacerbates Parkinson's |
|
|
Term
|
Definition
Carbamate ACHase inhibitors
DRUG of choice = more selective for CNS
Decrease apathy, hallucinations, anxiety and behavioral problems
S/E = diarrhea, muscle cramps, fatigue, insomnia, anorexia
|
|
|
Term
|
Definition
Slowly Reversible Carbamate ACHase inhibitors
Quaternary amine
MOA: Inhibits ACHase which increase ACh at the N2 receptor of NMJ
1. Used to manage (check TX) myasthenia gravis treatment
2. Atony of the GI and GU tracts
|
|
|
Term
|
Definition
Carbamate ACHase inhibitors
Longer-term p.o dosing used to treat myasthenia gravis
too much = cholinergic crisis
too little = myasthenic crisis |
|
|
Term
|
Definition
Carbamate ACHase inhibitors
quarternary amine
MOA: direct stimulation of cholinergic N2 receptors, extremely short half-life
TX: 1. diagnosis of myasthenia gravis
2. distinguish between "myasthenic" and cholinergic crisis in patients treated with p.o. pyridostigmine
|
|
|
Term
|
Definition
Carbamate ACHase inhibitors
(irreversible organophosphate inhibitors)
insecticide
Humans are poisoned with this... TX with ATROPINE
|
|
|
Term
|
Definition
Organophosphate AChase inhibitors
insecticide for lawns and gardens |
|
|
Term
|
Definition
Organophosphate AChase inhibitors
insecticide
1. converted to active metabolite by p450
2. causes many accidental deaths |
|
|
Term
|
Definition
Irreversible Organophosphate AChase inhibitors
Insecticide
1. used to kill lice
2. safer than parathion
3. used to kill mosquitos |
|
|
Term
|
Definition
TX of Organophosphate Poisoning
quarternary
NOT USE for carbamate insecticides |
|
|
Term
|
Definition
Muscarinic receptor antagonists
block peripheral and central muscarinics
* exhibits differential sensitivity to atropine sulfate
* not expressed when the drug is given in normal therapeutic doses
* decrease production of saliva or pulmonary secretions
* counteract bradycardia
* blocks SE of neostigmine and pyridostigmine |
|
|
Term
|
Definition
Muscarinic receptor antagonists
little effect on HR
causes somnolence, euphoria, amnesia, dreamless sleep
TX motion sickness |
|
|
Term
|
Definition
Muscarinic receptor antagonists
induces MYDRIASIS causing "pupillary block"
tertiary compound
|
|
|
Term
|
Definition
Muscarinic receptor antagonists
MYDRIASIS: short duration of action, needed for thorough examination of retina and optic disk
|
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary compounds
|
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary compound
|
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary compounds
GI Disease |
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary compound
GI disease: spasticity
|
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary compounds
TX overactive bladder
Direct Antispasmodic effect on detrusor
May cause drowsiness, somnolence, dizziness |
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary amine
* DO NOT USE IN ELDERLY
TX Overactive bladder
S/e somnolence, dry mouth, blurred vision, and constipation |
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary amine
Selective M3 muscarinic receptor
less dry mouth than oxybutnin, tolteridine and trospium
|
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary amine
no CNS or CV effects
less dry mouth compared to oxybutynin, tolteridine and trospium |
|
|
Term
|
Definition
Muscarinic receptor antagonists
tertiary compound
|
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary)
part of N-methyl PIG
|
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary)
quartenary cmpd |
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary) |
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary) |
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary)
* used to decrease the production of saliva/pulmonary secretions
* counteracts bradycardia caused by ocular pressure |
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary) |
|
|
Term
|
Definition
Muscarinic receptor antagonists (quaternary)
|
|
|
Term
|
Definition
nicotinic receptor agonists
1. Adverse effect on plasma lipid profile
2. endothelial cell dysfunction
3. increased platelet aggregation
4. neutrophil activation and aggregation
5. increased transcapillary escape of albumin
6. insulin resistance and hyperinsulinemia
7. cardiac dysrhymias via carbon monoxide |
|
|
Term
|
Definition
nicotinic receptor agonists
IV injection causes an initial, single contraction of skeletal muscle followed by a flaccid paralysis
Flaccid paralysis is caused by the constant depolarization of the motor endplate = noncompetitive block
degraded by plasma cholinesterase |
|
|
Term
|
Definition
N-1 receptor antagonis = ganglionic blocking drugs
used to produce controlled hypotension during head and neck injury
can also cause further dilation |
|
|
Term
|
Definition
N-1 receptor antagonis = ganglionic blocking drugs
controls symptoms from autonomic hyperreflexia by preventing the paroxysmal increases in sympathetic activity
|
|
|
Term
|
Definition
Adrenergic agonists
(selective for alpha 1)
Decrease HR
INDIRECT via baroreflexes
Increase TPR, Increase DBP
SV NOT CHANGED b/c Starling
Vasoconstrictive with local anesthetic or CO and tissue perfusion are normal |
|
|
Term
Dopamine
(including receptor preference)
|
|
Definition
D1 > B1 > alpha 1
small dose: dilates renal afferent arterioles (D1), increase RBF, GFR and sodium excretion
middle dose: stimulate both renal (D1) and myocardial (B1); increase in contractility, SV, CO, RBF, GFR
large dose: begins to stimulate resistance arterioles and venules (A1), increase in TPR and afterload, decrease SV/CO
|
|
|
Term
|
Definition
Beta 1 > Beta 2
Stimulates B 1 selectively
Blocks Alpha 1
Increase GFR
Arteriolar Dilation (B2): lowers TPR and DBP
Venodilation (B2): decrease Venous Return
No effects on HR at normal doses
Causes Tachycardia in excess
|
|
|
Term
|
Definition
Beta-Adrenergic Agonists
Increase HR by direct stimulation of the SA node
Increase AV conduction in AV block
Increase SV and PP
Decrease in DBP via Beta 2 stimulation
SBP unchanged
|
|
|
Term
|
Definition
B2 >> B1
Adrenergic Agonists
Relieve bronchoconstriction associated wit hasthma, COPD and bronchitis
Longer lasting than albuterol
|
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
B2 >> B1
* relaxes uterine smooth muscle in order to delay parturition
* relaxes uterine muslce to help fetus in breech
|
|
|
Term
|
Definition
pure alpha 1 receptor stimulation
Cardio effects are the same as NE
Increase SBP and DBP
no change in SV (pulse pressure)
Decrease HR via carotid baroreflex
Systemic vasoconstrictor
Relieves nasal congestion by constricting blood vessels
Produces MYDRIASIS for fundoscopic exam
|
|
|
Term
|
Definition
alpha only
nasal decongestant
longer duration of action than phenylephrine
|
|
|
Term
|
Definition
Adrenergic Agonists
acts at periphery
found in cheese, wine, beer and pickled herring
not therapeutic
|
|
|
Term
|
Definition
Adrenergic Agonists
d-; d,l-; methylphenidate : BLOCK uptake 1
- used to treat ADD
|
|
|
Term
|
Definition
MIXED AGONIST
B1 and B2 (bronchodilation and AV conduction in AV block)
Releases NE which act on alpha and Beta (MYDRIASIS, increased BP
and nasal decongestion)
net effect: increased BP, HR, CO, AV conduction
increased FEV, mydriasis, insomnia
|
|
|
Term
|
Definition
(Sudafed)
Adrenergic Agonists
less CNS excitation, BP, HR increase
Sinus decongestant
|
|
|
Term
|
Definition
A1 > A2
Alpha-adrenoceptor antagonist
* non-competitive receptor blockade due to alkylation of receptors
S/E: Fainting |
|
|
Term
|
Definition
Alpha-adrenoceptor antagonist (both strongly)
used to reverse ischemia and tissue necrosis caused by extravasated dopamine from veins during iv |
|
|
Term
prazosin (terazosin, doxazosin) |
|
Definition
Alpha 1 only -adrenoceptor antagonist
relieve urinary obstruction
prazosin ( treatment of peripheral vascular disease ie frostbite, vasospasm) |
|
|
Term
|
Definition
Alpha 1A-adrenoceptor antagonist
no alpha2
|
|
|
Term
|
Definition
beta-adrenoceptor antagonists
alpha -adrenoceptor antagonists
alpha 2 > alpha 1
causes tachycardia, tremor, and slight increase BP
lowers BP in hypertensive pts (not helpful in pheochromocytoma pts)
highly lipid soluble |
|
|
Term
|
Definition
Alpha 2 > Alpha 1
Alpha-adrenoceptor antagonist
|
|
|
Term
Ergotamine, dihyroergotamine |
|
Definition
Alpha-adrenoceptor antagonist
partial agonists
constricts cerebral blood vessels by acting as a partial alpha agonist
TX - migraine headache -- many s/e |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Beta-adrenoceptor antagonists |
|
|
Term
|
Definition
Beta-adrenoceptor antagonists
|
|
|
Term
|
Definition
Beta-adrenoceptor antagonists
short half-life
cardioselective beta1
|
|
|
Term
|
Definition
Beta-adrenoceptor antagonists
|
|
|
Term
|
Definition
Sympatholytic drugs
Decrease release of NE from sympathetic neurons --> Reducing TPR --> reducing BP
HR decreased, TPR decreased, DBP decreased
balanced vasodilation
TX hypertension in pregnant women and children because its not teratogenic |
|
|
Term
|
Definition
Sympatholytic Drugs
MAO: 1. destorys storage vesicles for neurotransmitter in central and peripheral neurons
2. NE release is not inhibited
Effects: Balanced Vasodilation
Decreased HR, CO is unchanged
S/E: teratogenic, orthostatic hypotension, sexual dysfunction
Chronic decrease in the neuronal release of NE results in up-regulation of a and B receptors -- supersensitivity |
|
|
Term
|
Definition
Sympatholytic Drugs - adrenergic neuronal blocking drug
* inhibition of NE release from peripheral sympathetic neurons
(Dilation of arterioles) Decrease TPR, BP
(Dilation of venules) Decrease in Venous Return
Balanced Vasodilation
HR unchanged, CO unchanged
|
|
|
Term
|
Definition
Alters NE Metabolism
MOA: 1. local anesthesia (blocks Na channels)
2. noncompetitive blockade of uptake 1 (NE accumlates in nerve junction = vasoconstriction)
3. acts centrally to increase peripheral sympathetic flow
4. euphoria and addiction from DA stimulation in nucleus accumbens
Increase BP and HR |
|
|
Term
Sodium
What happens when ion conductance is increased?
Decreased ion conductance? |
|
Definition
Increase = rapid depolarization
Decrease = no depolarization |
|
|
Term
Potassium
What happens when ion conductance is increased?
Decreased ion conductance?
|
|
Definition
Increase = rapid hyperpolarization
Decrease = decreased membrane potential membrane |
|
|
Term
Chloride
What happens when ion conductance is increased?
Decreased ion conductance?
|
|
Definition
Increase = rapid depolarization
Decrease = decreased membrane potential difference |
|
|
Term
Calcium
What happens when ion conductance is increased?
Decreased ion conductance?
|
|
Definition
Increase = slow depolarization
Decrease = no depolarization |
|
|
Term
A patient with increase ACh release.
How is ion conductance related?
Where type of receptors are involved and where are they located? |
|
Definition
Sodium ion conductance increases.
Coupled to N1-cholinergic receptors located in sympathetic and parasympathetic ganglia and N2 cholinergic receptors at the neuromuscular junction. |
|
|
Term
A patient given inhibitory amino acids would be expected to exhibit ______?
Name 2 inhibitory amino acids |
|
Definition
Increased Chloride Conductance
1. GABA
2. Glycine |
|
|
Term
Properties of lipid-solube compounds on transmembrane travel.
Name 3 important ones: |
|
Definition
They freely cross the cell memrbane and bind to cytoplasmic receptors.
Corticosteroids, Aldosterone, Vitamin D |
|
|
Term
Substance that increase Cl- conductance: |
|
Definition
Barbiturates
Volatile Anesthetic gases
propofol
ETHANOL |
|
|
Term
Role of excitatory amino acids on ion conductance.
Name two important ones. |
|
Definition
Increase in Sodium and Calcium conductance
1. Glutamate [kainate, AMPA, NMDA receptors]
2. Aspartate |
|
|
Term
What is the affect of Serotonin on Sodium conductance via 5-HT receptor? |
|
Definition
Increases sodium conductance |
|
|
Term
What happens during stimulation of Beta-adrenoceptors on G-protein receptors |
|
Definition
Activates adenyl cyclase -> cAMP -> degraded by PDEases to 5'-AMP
PDEases inhibited by theophylline, caffeine and papaverine |
|
|
Term
Describe intiation/termination of drug acction |
|
Definition
SLOW -- because the steps of protein synthesis must be changed |
|
|
Term
The mode of action of Thyroxine, estrogen and androgens |
|
Definition
Alter gene transcription after binding to recepors in the nucleus or on DNA |
|
|
Term
Biological affect of reversible phosphorylation |
|
Definition
Allows amplification of the signal and persistence of the biological effect after receptors are non longer stimulated by an agonist |
|
|
Term
What secondary messengers are involved control smooth muscle control? |
|
Definition
|
|
Term
The increase of intracellular Calcium signals what in cells? |
|
Definition
Enhanced cellular function. |
|
|
Term
If cAMP increases, what will happen to free intracellular Calcium? |
|
Definition
Cannot say. It may have no effect on free intracellular Calcium
Ex. Beta2 adrenoceptors causes relaxation of vascular smooth muscle |
|
|
Term
What is the loading dose and how is it determined? |
|
Definition
Loading dose is administered in order to achieve a plasma drug concentration within the therapeutic window quickly.
= Concentration in plasma x Dist. Vol ------------------------------------ Bioavailability (F, no units) |
|
|
Term
|
Definition
Vascular endothelial cells - constitutive
Marcophages, neutrophils, smooth muscle cells - induced by cytokines |
|
|
Term
Physiologic Actions of NO |
|
Definition
Vasodilation
Decrease BP
inhibits platelet adhesion and aggregation
inhibts neutrophil adhesion to vascular endo
neurotransmitter in CNS
Erection |
|
|
Term
Nitrous Oxide action on cell |
|
Definition
Directly activates cytoplasmic Guanyl cyclase -> increased intracellular cGMP -> MLC phosphatase activated and dephosphorylates -> relaxes VSM = contraction |
|
|
Term
|
Definition
Increased intracellular cGMP and vasodilation because it inhibits PDEase |
|
|
Term
Arrange receptors in the time needed to turn on/off from fastest to slowest |
|
Definition
ION Channel < Enzyme < Transcription of mRNA (protein) |
|
|
Term
Formula and Definition for affinity |
|
Definition
= 1/Kd = 1/ (k2/k1)
ability of drug to form a stable complex with receptor
|
|
|
Term
|
Definition
Biological effectiveness of a drug receptor complex
- quantal response when one drug molecules occupies one receptor |
|
|
Term
Biggest difference between competitive and non-competitive inhibitors |
|
Definition
Competitive = reversible
Non-competitive = irrversible
for non competive -- tissue must synthesize new receptors before the reponse to the agonist can be restored completely |
|
|
Term
|
Definition
|
|
Term
Feature pharmacokinetic tolerance |
|
Definition
Drug metabolism is increased so plasma concentration of drug falls since dosing remains constant |
|
|
Term
Feature of Pharmacodynamic tolerance |
|
Definition
the tissue response to the drug dimishes
a. decrease in receptor number
b. decrease in efficiency of signal transduction
example: ethanol |
|
|
Term
|
Definition
Development of tolerance to one drug as a result of prior exposure to another drug. |
|
|
Term
HOw to read Scatchard plot |
|
Definition
If intercept of x-axis moves right = increase receptor
If interecept of x-axis moves left = decrease receptor
Steeper slope = greater the affinitu |
|
|
Term
|
Definition
Efficacy - max clinical effect (which one does the most)
Potency - the dose of drug required to achieve a particular affect |
|
|
Term
|
Definition
LD (50)/ ED (50)
Death / Anesthesia of 50% of subjects |
|
|
Term
Pharmacodynamics vs. Pharmacokinetics |
|
Definition
PDynamics -What the drug does to your body
PKinetics - What your body does to the drug |
|
|
Term
Enteral routes of drug administration and speed |
|
Definition
Buccal - rapid, high FIRST PASS
Per os - absorption is low
Rectal - decreased FIRST PASS |
|
|
Term
Parenteral Drug Administration and speed |
|
Definition
IV - rapid
IM - rapid, good for depot
SQ - rapid for aqueous preps
Intrathecal - high local concentration |
|
|
Term
Where are basic drugs best absorbed? |
|
Definition
Small Bowel because the relative absence of hydrogen ions |
|
|
Term
Where are acidic drugs are best absorbed? |
|
Definition
In the STomach because the superabundance of hyrogen ions |
|
|
Term
Determine Lipid Solubility |
|
Definition
Oil/Water coefficient
10 is very soluble and will easily pass through membranes
0.1 indicates that the drug is poorly lipid-soluble |
|
|
Term
Where's is most drug absorbed regardless of pKa |
|
Definition
small intestine because of its large surface area |
|
|
Term
Hepatic Biotransformation |
|
Definition
makes drugs more water soluble so that they can be excreted by the kidney |
|
|
Term
|
Definition
Drug is metabolized by the liver soon after absorption and keeps it out of systemic circulation |
|
|
Term
Two phase Biotransformation |
|
Definition
Phase 1 - changes the chemical structure of the drug by oxidation, hydroxylation, deamination and dealkylation
Phase 2 - involve the conjugation of drugs to endogenous compounds |
|
|
Term
A major cause of drug toxicity______ |
|
Definition
|
|
Term
|
Definition
By manipulating the urinary PH we can keep ions in the urine
- acidic things are trapped in the urine by an acidic pH
- basic things are trapped/excreted in urine by alkaline pH |
|
|
Term
Free drug travel in interstitial fluid and cell membranes |
|
Definition
Free drug travels easily through capillaries to interstitial fluid
Free drug has difficulty passing through cell membranes unless it is very lipid or actively transported |
|
|
Term
|
Definition
(F) Fraction of drug dose that reaches systemic circulation as unchanaged drug following extravascular dosing |
|
|
Term
If "apparent volume" or distribution or Vd is greater than 0.6 -- what does that indicate? |
|
Definition
That drug is being retained in the tissues. |
|
|
Term
Describe Zero-order kinetics |
|
Definition
A CONSTANT amount of drug is eliminated per unit of time |
|
|
Term
Describe drug elimination follows first-order kinetics. |
|
Definition
A constant faction of drug is eliminated per unit of time. ex. 10% drug/h |
|
|
Term
Why is the body able to eliminate a constant fraction of drug per unit of time. |
|
Definition
First order kinetics so there is never saturation of drug. |
|
|
Term
Elimination rate is synonomous with what |
|
Definition
fractional rate constant (First order kinetics) |
|
|
Term
Formula for elimination rate constant (K) |
|
Definition
|
|
Term
|
Definition
Plasma Concentration at steady state occurs after 4 half-lifes. |
|
|
Term
Hepatic Clearance formula |
|
Definition
Cl = rate out/ Concentration in plasma |
|
|
Term
|
Definition
= ((Concentration in urine x Uvol/t) ----------------------------- Concentration of drug in plasma |
|
|
Term
|
Definition
0-120 = drug filtered and partially abs 120 = drug filtered not absorbed (creatinine and inulin) 120-600 = drug secreted and partially reabs 600 = drug secreted and not reabsorbed (PAH) |
|
|
Term
|
Definition
= total amt of drug in the body x k |
|
|
Term
After iv administration the plasma concentration of drug drops quickly then declines steadily. What accounts for this early disappearance of drug? |
|
Definition
It is NOT due to the elimination of drug from the body. |
|
|
Term
How does administration of a loading dose affect the time needed to reach plasma concentration steady state? |
|
Definition
Loading dose does not shorten the time that it takes to reach Cp steady state. |
|
|
Term
How do Cp steady state and Cp from a single p.o. dose compare? |
|
Definition
Cp steady state is always greater than single dose |
|
|
Term
What happens to half-life of a drug when renal excretion is decreased due to injury? |
|
Definition
The half-life is increased. |
|
|
Term
Main sign of hepatic dysfunction. |
|
Definition
|
|
Term
What is the relationship between in the Cp(ss) and the dosing rate |
|
Definition
They are proportional: increase in one is an increase in the other |
|
|
Term
Pulse Pressure (calc & determining factors) |
|
Definition
= Systolic - diastolic * determined by SV and Arterial Compliance |
|
|
Term
|
Definition
function of the aorta and large arteries that result in wall stretch to accomodate extra volumes of blood - gives rise to the peripheral pulse (radial etc) - generated by LV systole |
|
|
Term
Describe laminar flow (blood) |
|
Definition
RBC's flowing closer to the vessel wall have a slower velocity due to bumping and resistance |
|
|
Term
Determinant of Diastolic Blood Pressure (DBP) |
|
Definition
TPR in 4th and 5th order arterioles - controlled by sympathetic nerve activity |
|
|
Term
Systolic blood pressure (SBP) determinants |
|
Definition
a. SV b. arterial compliance c. DBP |
|
|
Term
Synonyms for Venous Return |
|
Definition
PRELOAD LV-EDP LV-EDV R atrial pressure cardiac filling pressure pulmonary capillary wedge pressure venous capacitance |
|
|
Term
Determinants of Venous Return (aka preload/LV-EDP) |
|
Definition
Blood volume distribution of the blood volume venous capacitance - atrial contractility |
|
|
Term
Relationship of HR and CO in adults |
|
Definition
HR is only a minor determinant, the greater influence is venous return |
|
|
Term
Relationship of CO and HR in children |
|
Definition
Increase in HR will increase CO b/c LV is so small and fills quickly |
|
|
Term
|
Definition
"The heart pumps what it gets" - increase venous return = incrase LV wall pressure in diastole - increased contractility - increase venous return |
|
|
Term
|
Definition
is TPR such arterial constriction = increased afterload |
|
|
Term
Stroke Volume determinants |
|
Definition
a. preload b. cardiac contractility c. afterload (negatively related) |
|
|
Term
Afferent input from carotid sinus constantly _______________ |
|
Definition
inhibits efferent sympathetic outflow and stimulates efferent vagal outflow |
|
|
Term
Describe vagal and sympathetic nerve activity at increased BP |
|
Definition
* decreased sympathetic nerve activity * increased vagal activity |
|
|
Term
Decrease in afferent nerve activity from the carotid sinus causes what increase? what receptors are stimualted? |
|
Definition
a disinhibition of efferent sympathetic activity * increase in Beta-1 = increased contractility * Alpha-1 = arterial (DBP) and venous constriction (venous return and CO) |
|
|
Term
Increase in vagal nerve activity causes |
|
Definition
1. decrease in HR and AV conduction 2. DIRECT Suppression of atrial contractility 3. slight decrease in ventricular contractility due to NE inhibition from sympathetic fibers |
|
|
Term
Where is efferent sympathetic nerve activity generated |
|
Definition
RVLM Rostral ventrolateral medulla |
|
|
Term
|
Definition
Increase in intrathoracic pressure causes baroreceptor to results in increase vagal stimulation leading to great drop in BP |
|
|
Term
|
Definition
Symp and Parasymp ganglia
Adrenal Medulla |
|
|
Term
|
Definition
Cholinergic
Motor end plate of skeletal muscle |
|
|
Term
Location of Muscarinic Receptors |
|
Definition
Smooth muscle (bladder, intestine, lungs, heart)
Sweat glands
Prejunctional sites of on symp & parasymp neurons
Surface of endothelial cells |
|
|
Term
|
Definition
ALPHA-1 Adrenergic:
Contraction = mydriasis
|
|
|
Term
|
Definition
Cholinergic (muscarinic)
Contraction = MIOSIS (decrease in size) |
|
|
Term
|
Definition
Cholinergic (muscarinic)
Contraction = near vision |
|
|
Term
|
Definition
prevents ACh synthesis by blocking choline uptake |
|
|
Term
Inhibitors of ACh release |
|
Definition
hemicholinium
ACh - on its own M2 receptors
NE - Alpha 2 on heteroreceptors
Opiates - inhibts in GI tract |
|
|
Term
What amplifies ACh release in GI Tract? |
|
Definition
|
|
Term
|
Definition
MOA: binds to surface protein and transported into cholinergic neurons; protease hydrolyzes protein involved in synaptic storage and exocytotic release of ACh
3. Cholinergic neurotransmission ceases in the nerves which supply the NMJ
|
|
|
Term
|
Definition
Causes: spastic paralysis
* acts within the spinal cord preventing release of inhibitory neurotransmitter |
|
|
Term
|
Definition
causes the excess release of ACH by binding to neurexins in plasma membrane |
|
|
Term
|
Definition
enzyme that chews up acetylcholine
localized: neuronal membranes, NMJ, RBC's
Recovery time: 2-3 months |
|
|
Term
|
Definition
preferred substrates: succinylcholine
procaine
localization: plasma, liver, brain, GI smooth muscle
Recovery: 2 weeks |
|
|
Term
Name and describe the two routes of aqueous humor circulation in the eye |
|
Definition
Pressure Pathway = flow through anterior part of lens --> anterior chamber --> exit Canal of Schlemm (IC angle) --> trabeculae
Uveoscleral = flow into spaces within the ciliary muscle and tissue surrouding sclera (5-25% of normal outflow) |
|
|
Term
Intraocular Pressure
(define & utility as indicator) |
|
Definition
Pressure measured on the anterior chamber of the eye
clinical indicator for glaucoma |
|
|
Term
|
Definition
narrowing of the IC angle inhibiting outflow
Cause: MYDRIASIS (which can be drug induced by cyclopentolate)
Symptoms: blurred vision, pain, redness, sweating, nausea, vomiting
|
|
|
Term
|
Definition
(95% of patients)
flow of aqueous humor through Canal of Schlemm is impeded due to poor tone or alignment of trabeculae
|
|
|
Term
Drugs classes necessary to treat IOP
(name the drugs in each class) |
|
Definition
3 drugs that do the following:
1. Decreases Outflow normal path
* Beta adrenoreceptor antagonist
* Carbonic anhydrase inhibitors
* alpha adrenoceptor agonists
2. Increase Outflow normal path
* PGF (2 alpha) analogs
3. Increase Outflow the Uveoscleral path
* alpha adrenoceptor agonists
* pilocarpin, isofluophate |
|
|
Term
|
Definition
Selective alpha 2 adrenoceptor agonists
Decrease the rate of production of aq. humor |
|
|
Term
|
Definition
Stable analog of PGF (2alpha)
increase uveoscleral outflow
not as good a latanoprost |
|
|
Term
|
Definition
Immunosupressant drug using with pyridostigmine for long-term p.o dosing to treat myasthenia gravis |
|
|
Term
Clues for insecticide poisoning affecting muscarinic receptors |
|
Definition
Miosis, bradycardia, cough, abdominal cramps, sweating and salivation, urinary frequency |
|
|
Term
Clues of insecticide affecting nicotini manifestations |
|
Definition
msk - weakness, cramping
symp ganglia - tachycardia, hypertension |
|
|
Term
TX of Organophosphate Poisoning |
|
Definition
Atropine sulfate (tertiary) - block peripheral and central muscarinics
Praidoxime (quartenary) - regenerates enzyme in periphery |
|
|
Term
TX of Carbamate insecticides (carbaryl) |
|
Definition
|
|
Term
Metabolic effects of IV infusion of EPI and NE during excercise or hypoGlycemia
Glucose (plasma)
Insulin release
FFA (plasma)
Lactic A (plasma)
Oxygen consump
K (plasma)
|
|
Definition
EPI NE
Glucose (plasma) B2 ++ 0/+
Insulin release A2 - -
FFA (plasma) B1 ++ 0/+
Lactic A (plasma) B2 ++ 0/+
Oxygen consump ++ 0/+
K (plasma) B2 ++ 0/+
|
|
|
Term
CNS effects of EPI and NE during excercise
Anxiety
Respiration
Tremor |
|
Definition
EPI NE
Anxiety ++ 0/+
Respiration + +
Tremor + +/0 |
|
|
Term
Selectivity of EPI and NE |
|
Definition
EPI = Beta 2 (arterial msk)> Beta 1 > alpha
NE = alpha (arterial GI & kid.) > beta1 > beta 2 |
|
|
Term
|
Definition
small iv dose:
Increase vasodilation (Beta 2)
Decrease in TPR and DBP
Increase in SV, SBP, contractility
Large iv dose:
Vasoconstriction (alpha)
Increase TPR and DBP
Increase in SV, SBP, contractility
* blood decreases in kidney, GI tract and skin |
|
|
Term
Epinephrine (lung, local, anaphylactic use) |
|
Definition
alpha and beta
bronchodilator in astma and COPD patients
Vasoconstrictive w/ local anesthetic
DOC for TX anaphylactice reactions (reverse bronchoconstriction and laryngeal edema)
DOC for releaving priapism (alpha receptor stim)
* though may damage kidney |
|
|
Term
Stroke Volume:
Normal vs. Myocardial Infarction
(increased preload, contractility, afterload) |
|
Definition
normal heart MI
increase preload inc dec
increased contractility inc inc
increased afterload n.c. DEC |
|
|
Term
|
Definition
releases nitric oxide which dilates both arterioles and venules
can be given by iv infusion during MI along with dobutamine |
|
|
Term
Dobutamine advantages over dopamine in tx of MI |
|
Definition
1. does not increase DBP (afterload)
is less likely to cause tachycardia
causes venodilation which decreases venous return (preload), so cardiac filling pressure is decreased |
|
|
Term
|
Definition
Epinephrine causes increase in BP with alpha and b2 receptor stimulation
if alpha antagonist is used (phenoxy, phentolmine, prazosin, tamsulosin, labetalol, yohimbine) then it depresses the BP even more than the antagonist
However if you use a non-selective beta antagonist then give epi -- the spike in BP is greater |
|
|
Term
Hypertensive patient, normal cardiac function, alph receptor blocker PRAZOSIN
Effect on TPR, BP, Venous Capacitance, HR, dp/dt, CO |
|
Definition
decrease TPR
decrease BP
Increase VC
balanced dilation so no change in the following:
HR, Contractility, CO |
|
|
Term
How treat prostatic hypertrophy? |
|
Definition
Doxazosin
Terazosin
Tamsulosin |
|
|
Term
Treatment of Erectile Dysfunction |
|
Definition
Phentolamine
Papaverine
Alprostadil
Sildenafil |
|
|
Term
Side effects of alpha antagonists (alpha blockers) |
|
Definition
hypotension
angina
failure to ejaculate
miosis
nasal congestion
abdominal cramps
retention of water and salt |
|
|
Term
Name the Beta-blockers for the heart
& selectivity |
|
Definition
BAM
Betaxolol
Atenolo
Metoprolol
B1 selective
Propranolol
Timolol
non-selective
Esmolol - short half life |
|
|
Term
|
Definition
HR decrease
Prevent Tachycardia caused by excercise, stress
also decrease conduction, AV, Ventricles, dp/dt, CO, Coronary Blood flow
BP is decreased
initial reduction in CO |
|
|
Term
Beta blockers on the kidney |
|
Definition
Plasma renin and angiotenin II fall
decline in BP
Salt and Water retention |
|
|
Term
Beta Block effect on lung |
|
Definition
Increased Airway resistance decrease FEV1
BAM has the least decrease in FEV while propranolol and timolol have the greatest decrease |
|
|
Term
|
Definition
Reduce blood flow
pts. compain of cold hands |
|
|
Term
Beta-blocker effect on the eye |
|
Definition
Reduce IOP by decreasing production of aq. humor |
|
|
Term
Beta-blocker on metabolism |
|
Definition
blocks the increase FFA (plasma) cause by smp stimulation of B1 in fat
Blocks B2 glycogenolysis in liver and skeletal muslce |
|
|
Term
Therapeutic uses of Beta blockers |
|
Definition
Cardiac dysrhytmias (especially catecholamine induced) especially in MI pts (decrease chance of death)
Heart failure (diastolic dysfunction - tx with carvedilol or metoprolol)
Hyperthyroidism (block trmor, tachycardia)
Pheochromocytoma, Glaucoma, essential tremor, mirgraines, portal hypertension (propranolol) |
|
|
Term
Adverse effects of Beta blockers |
|
Definition
Depressed mycoardial contractility
Bradycardia
Up-regulation of B-adrenoceptors due to withdrawl of propranolo
Asthma
Diabetes (mask warning signs except sweating)
Digital Blood Flow decrease
Excercise Intolerance |
|
|
Term
Toxicity associated with Cocaine use |
|
Definition
1. Cardia dysrhythmias
2. MI
3. Chest pain
4. Pulmonary Edema
5. CVA - subarachnoid hemorrhage
6. Necrosis of nasal septum
7. Seizure
8. Resp. Disease
9. Sudden death |
|
|
Term
What drugs are used to determine refractive error? |
|
Definition
Scopolamine, atropine, or cyclopentolate
MYDRIASIS and cycloplegia |
|
|
Term
How do you treat anterior uveitis and choroiditis |
|
Definition
|
|
Term
What is the treatment for diarrhea |
|
Definition
Diphenoxylate (opiate) inhibits GI motility
+
Atropine |
|
|
Term
Drugs to treat Overactive Bladder |
|
Definition
STOp the Darn Tinkling
Oxybutynin
Tolterodine
Trospium
Solifenacin
Darifenacin |
|
|
Term
|
Definition
Tioptropium and Ipratropium |
|
|
Term
Compounds the block central muscarinic receptors |
|
Definition
BBATS in the belfry
Benxtropine
Biperiden
Atropine
Trihexyphenidyl
|
|
|
Term
Describe Atropine Toxicity |
|
Definition
Red as a beet (cutaneous dilation)
Hot as a pistol (hot skin)
Mad as a hatter (delusions)
Dry as a Desert (inhibit salivation)
CNS - nervous, excitation, confusion, hypertension, etc
PNS - dry mouth, thirst, dilated pupils, tachycardia, photophobia |
|
|
Term
N1 Receptor Antagonists
describe MOA |
|
Definition
Competitive bloackade of N1 cholinergic receptors in autonomic ganglia prevents all symp/parasymp nerve activity from reaching the effector organs |
|
|
Term
Blockade of Symp Ganglia Cause: |
|
Definition
Decrease TPR
decrease venodilation
decrease contractility
decreased cardiac output
hypotension
decreased sweating
impotence |
|
|
Term
Blockade of Parasympathetic Ganglia |
|
Definition
Tachycardia
Mydriasis and cycloplegia
decreased salivation & lacrimation
decreased GI secretion, motility and tone
decreased gastric acid secretion
decrease release of pancreatic enzymes and bile
constipation and urinary retention
impotence (no erection) |
|
|
Term
|
Definition
Chewing gum
Transdermal
Nasal Spray |
|
|
Term
|
Definition
perscription antidepressant drug taken p.o.
can cause seizure |
|
|
Term
|
Definition
partial agonist at central alpha and beta nicotinic receptors whose effects mimic tobacco
* causes the release of dopamine |
|
|
Term
Atropine is given as a treatment for ______ |
|
Definition
SLUDGE
Salivation
Lacrimation
Urination
Diaphoresis
GI motility
Emesis |
|
|
Term
|
Definition
X (loading dose) = ((Cp x Vd)/F) |
|
|
Term
What comprises the uveal tract (uveoscleral route) |
|
Definition
Iris, ciliary body, ciliary muscle, choroid |
|
|
Term
TX of Open-Angle Glaucoma |
|
Definition
1. Muscarinic receptor:
Pilocarpine - allow flow
Alpha agonist - Epi, Apraclonidine & Brimonidine (alpha 2 selective), Dipivefrin
Beta antagonist - betaxolol, timolol
Carbonic Anhydrase inhibitor - acetazolamide, dorzolamide
2. Inhibitors of AChase - Isoflurophate and echothiophate |
|
|
Term
TX of acute attack of angle closure glaucoma |
|
Definition
Mannitol - given iv
causes cellular deydration
|
|
|
Term
|
Definition
DTP
Tacrine
Donepezil
Physostigmine |
|
|
Term
Quartenary Cholinomimetic Drugs |
|
Definition
Neostigmine
Pyridostigmine
Edrophonium |
|
|
Term
Irreversible Inhibitors of Achase |
|
Definition
organophosphate
DIMPLE
Dimpylate
Isoflurophate
Malathion
Parathion
L
Echothiophate |
|
|
Term
Muscarinic Antagonists: Quartenary Compounds |
|
Definition
N methyl PIG
N-methylatropine
N-methylhomatropine
methscopolamine
propantheline
ipratropium
glycopyrrolate
TT
Trospium
tiotropium |
|
|
Term
Muscarinic Antagonist Quartenary
(RAP) |
|
Definition
Atro - Sco - Ho - Cy
Tropic - Benz Tri
Bi Di hyo- Oxy
To So Da Di |
|
|